According to Wikipedia, venture capital (VC) is financial capital provided to early-stage, high-potential, high-risk start-up companies on the back of a novel technology or business model – so is it really any wonder so much emphasis is placed on maintaining the confidentiality of information related to an entrepreneur’s innovation, novel technology or business model?

While we encourage a robust trade secret policy, as well as the use of non-disclosure agreements (NDAs) when the situation calls for it, start-ups often jump to the latter with- out considering whether an NDA is appropriately crafted or, more likely, whether it is appropriate at all.

Historically, venture capitalists (VCs) have been loath to sign NDAs, a position which has evolved for a variety of reasons.

Though NDAs are often viewed as commonplace, start-ups must remember that they are, at heart, a legally binding document. Most VCs are unwilling…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?


Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
GCV Institute: Landing the Value of Corporate Venturing
May 6 -
May 9, 2024
Webinar: CVCs and the art of the follow-on
May 8, 2024
GCV Institute: CVC Investment Programs
May 21 -
May 22, 2024
GCV Symposium 2024
Jun 24 -
Jun 26, 2024
London (UK)
Corporate Venture in Brasil 2024 – International Delegation to Brazil
Oct 28 -
Oct 30, 2024
São Paulo (Brazil)